Fulgent Genetics Inc (NAS:FLGT)
$ 21.74 -0.37 (-1.67%) Market Cap: 650.55 Mil Enterprise Value: 368.33 Mil PE Ratio: 0 PB Ratio: 0.58 GF Score: 74/100

Q4 2022 Fulgent Genetics Inc Earnings Call Transcript

Feb 28, 2023 / 09:30PM GMT
Release Date Price: $32.79 (+0.37%)
Operator

Hello, and welcome to the Fulgent Genetics Q4 and Fiscal Year 2022 Earnings Conference Call and webcast. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to Melanie Solomon, Investor Relations. Please go ahead.

Melanie Solomon
The Blueshirt Group, LLC - MD

Thanks, Kevin. Good afternoon, and welcome to the Fulgent Genetics fourth quarter and full year 2022 financial results conference call. On the call are Ming Hsieh, Chief Executive Officer of Fulgent; Paul Kim, Chief Financial Officer of Fulgent; and Brandon Perthuis, Chief Commercial Officer of Fulgent. The company's press release discussing the financial results is available on the Investor Relations section of the company's website, www.fulgentgenetics.com. A replay of this call will be available shortly after the call concludes on the Investor Relations section of the company's website.

Management's prepared remarks and answers to your questions on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot